最終更新日：2025/11/25
After reviewing the clinical data, the committee concluded that rofecoxib posed an unacceptable cardiovascular risk and recommended its withdrawal from the market.
正解を見る
After reviewing the clinical data, the committee concluded that rofecoxib posed an unacceptable cardiovascular risk and recommended its withdrawal from the market.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
